Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.
Saved in:
| Title: | Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry. |
|---|---|
| Authors: | Simonsen CS; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Flemmen HØ; Department of Neurology, Telemark Hospital Trust, Skien, Norway.; Institute of Health and Society, University of Oslo, Oslo, Norway., Broch L; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Brunborg C; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway., Berg-Hansen P; Department of Neurology, Oslo University Hospital, Oslo, Norway., Moen SM; Multiple Sclerosis Centre Hakadal, Grønvoll, Norway., Celius EG; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. |
| Source: | Frontiers in neurology [Front Neurol] 2021 Jun 17; Vol. 12, pp. 693017. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34220694 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Simonsen+CS%22">Simonsen CS</searchLink>; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Flemmen+HØ%22">Flemmen HØ</searchLink>; Department of Neurology, Telemark Hospital Trust, Skien, Norway.; Institute of Health and Society, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Broch+L%22">Broch L</searchLink>; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Brunborg+C%22">Brunborg C</searchLink>; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Berg-Hansen+P%22">Berg-Hansen P</searchLink>; Department of Neurology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Moen+SM%22">Moen SM</searchLink>; Multiple Sclerosis Centre Hakadal, Grønvoll, Norway.<br /><searchLink fieldCode="AU" term="%22Celius+EG%22">Celius EG</searchLink>; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101546899%22">Frontiers in neurology</searchLink> [Front Neurol] 2021 Jun 17; Vol. 12, pp. 693017. <i>Date of Electronic Publication: </i>2021 Jun 17 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101546899 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2295 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642295%22">16642295 </searchLink><i>NLM ISO Abbreviation: </i>Front Neurol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34220694 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fneur.2021.693017 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 693017 Titles: – TitleFull: Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Simonsen CS – PersonEntity: Name: NameFull: Flemmen HØ – PersonEntity: Name: NameFull: Broch L – PersonEntity: Name: NameFull: Brunborg C – PersonEntity: Name: NameFull: Berg-Hansen P – PersonEntity: Name: NameFull: Moen SM – PersonEntity: Name: NameFull: Celius EG IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 06 Text: 2021 Jun 17 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 1664-2295 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in neurology Type: main |
| ResultId | 1 |
